Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04543942 · ClinicalTrials.gov registry record · NA
Sex Differences in Risk for Alcohol Abuse
A NA study, sponsored by Mark Fillmore.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04543942: Completed NA study, sponsored by Mark Fillmore.
NCT04543942 is a NA study that has completed, run by Mark Fillmore. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04543942, a NA study, has completed, sponsored by Mark Fillmore.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study will determine the neural and hormonal mechanisms underlying sex differences in sensitivity to the disinhibiting effects of alcohol in heavy drinkers.
Primary Outcome
Brain activation during response inhibition (BARI) was assessed using blood oxygenation level dependent (BOLD) fMRI during performance of the stop signal task during alcohol (60mg%) infusion. Values were determined by the contrast of BOLD activation during successful inhibition trials relative to go trials.
Interventions
- DRUG Saline
- DRUG Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2023-05-24 |
| Phase | NA |
What the finished NCT04543942 record still lists
NCT04543942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT04543942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04543942 about?
NCT04543942 is a clinical study titled "Sex Differences in Risk for Alcohol Abuse". This study will determine the neural and hormonal mechanisms underlying sex differences in sensitivity to the disinhibiting effects of alcohol in heavy drinkers.
What is the current status of trial NCT04543942?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-11-01. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT04543942?
The interventions under investigation include: Saline (DRUG), Alcohol (DRUG).
Who is sponsoring clinical trial NCT04543942?
This trial is sponsored by Mark Fillmore, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04543942's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI